Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples